PharmaResearch Co., Ltd. (214450.KQ)

KRW 259500.0

(2.77%)

Total Assets Summary of PharmaResearch Co., Ltd.

PharmaResearch Co., Ltd.'s latest annual total assets in 2023 was 535.28 Billion KRW , up 11.97% from previous year.
PharmaResearch Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 601.47 Billion KRW , up 3.93% from previous quarter.
PharmaResearch Co., Ltd. reported annual total assets of 478.05 Billion KRW in 2022, up 11.79% from previous year.
PharmaResearch Co., Ltd. reported annual total assets of 427.64 Billion KRW in 2021, up 33.71% from previous year.
PharmaResearch Co., Ltd. reported quarterly total assets of 601.47 Billion KRW for 2024 Q2, up 3.93% from previous quarter.
PharmaResearch Co., Ltd. reported quarterly total assets of 535.28 Billion KRW for 2023 FY, up 11.97% from previous quarter.

Annual Total Assets Chart of PharmaResearch Co., Ltd. (2023 - 2015)

Historical Annual Total Assets of PharmaResearch Co., Ltd. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	535.28 Billion KRW	11.97%
2022	478.05 Billion KRW	11.79%
2021	427.64 Billion KRW	33.71%
2020	319.83 Billion KRW	18.49%
2019	269.92 Billion KRW	4.55%
2018	258.18 Billion KRW	35.27%
2017	190.87 Billion KRW	5.38%
2016	181.13 Billion KRW	6.28%
2015	170.44 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	578.71 Billion KRW	8.12%
2024 Q2	601.47 Billion KRW	3.93%
2023 FY	535.28 Billion KRW	11.97%
2023 Q2	503.74 Billion KRW	2.15%
2023 Q1	493.12 Billion KRW	3.15%
2023 Q3	535.09 Billion KRW	6.22%
2023 Q4	535.28 Billion KRW	0.03%
2022 Q3	462.43 Billion KRW	5.29%
2022 Q4	478.05 Billion KRW	3.38%
2022 FY	478.05 Billion KRW	11.79%
2022 Q2	439.19 Billion KRW	0.69%
2022 Q1	436.17 Billion KRW	1.99%
2021 FY	427.64 Billion KRW	33.71%
2021 Q1	331.49 Billion KRW	3.65%
2021 Q4	427.64 Billion KRW	19.15%
2021 Q3	358.91 Billion KRW	6.01%
2021 Q2	338.57 Billion KRW	2.14%
2020 Q3	309.05 Billion KRW	8.52%
2020 FY	319.83 Billion KRW	18.49%
2020 Q4	319.83 Billion KRW	3.49%
2020 Q1	273.73 Billion KRW	1.41%
2020 Q2	284.78 Billion KRW	4.04%
2019 Q3	264.21 Billion KRW	1.03%
2019 FY	269.92 Billion KRW	4.55%
2019 Q4	269.92 Billion KRW	2.16%
2019 Q2	261.5 Billion KRW	0.96%
2019 Q1	259.01 Billion KRW	0.32%
2018 Q1	233.69 Billion KRW	23.63%
2018 FY	258.18 Billion KRW	35.27%
2018 Q4	258.18 Billion KRW	1.89%
2018 Q3	253.39 Billion KRW	-0.06%
2018 Q2	253.54 Billion KRW	8.49%
2017 Q3	194.21 Billion KRW	6.68%
2017 Q2	182.05 Billion KRW	-0.24%
2017 Q1	182.49 Billion KRW	1.77%
2017 Q4	189.03 Billion KRW	-2.67%
2017 FY	190.87 Billion KRW	5.38%
2016 Q3	182.02 Billion KRW	0.0%
2016 Q1	- KRW	-100.0%
2016 Q4	179.33 Billion KRW	-1.48%
2016 FY	181.13 Billion KRW	6.28%
2015 FY	170.44 Billion KRW	0.0%
2015 Q4	169.3 Billion KRW	0.0%

Peer Total Assets Comparison of PharmaResearch Co., Ltd.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	28.793%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-442.801%
BINEX Co., Ltd.	257.01 Billion KRW	-108.271%
Bioneer Corporation	315.48 Billion KRW	-69.668%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-258.211%
MEDIPOST Co., Ltd.	449.39 Billion KRW	-19.112%
CrystalGenomics, Inc.	243.11 Billion USD	-120.176%
Helixmith Co., Ltd	227.27 Billion KRW	-135.517%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	68.979%
Medy-Tox Inc.	611.62 Billion KRW	12.482%
Peptron, Inc.	52.49 Billion KRW	-919.661%
Amicogen, Inc.	467.09 Billion KRW	-14.597%
Genexine, Inc.	376.58 Billion KRW	-42.14%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	-166.581%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-182.467%
ALTEOGEN Inc.	256.09 Billion KRW	-109.013%
SillaJen, Inc.	76.71 Billion KRW	-597.754%
JETEMA, Co., Ltd.	252.14 Billion KRW	-112.289%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-420.575%
Genomictree Inc.	132.84 Billion KRW	-302.94%
MedPacto, Inc.	80.47 Billion KRW	-565.157%
D&D Pharmatech	79.2 Billion KRW	-575.829%
EASY BIO,Inc.	172.04 Billion KRW	-211.135%
GI Innovation, Inc.	81.34 Billion KRW	-558.077%